Data Sciences and Informatics
数据科学和信息学
基本信息
- 批准号:10477235
- 负责人:
- 金额:$ 23.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-15 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressApplications GrantsAreaArtificial IntelligenceBasic ScienceBioinformaticsBiologicalBiologyBiomedical ComputingBiometryClinicalClinical Trials DesignComputer softwareComputerized Medical RecordCustomCutaneousDataData ScienceData SetData StoreDatabasesDermatologyDiseaseEpidemiologyEvaluationExtramural ActivitiesFacultyGenerationsGeneticGenomicsGoalsHealth systemHumanInformaticsKnowledgeMachine LearningMeasurementMedicalMedical InformaticsMedical RecordsMetagenomicsMethodologyMethodsNatureOutcome StudyPatternPennsylvaniaPhenotypeProteomicsReproducibilityResearchResearch DesignResearch PersonnelResearch Project GrantsResourcesScienceServicesSkinSourceSubjects SelectionsTextureTranslational ResearchTranslationsUniversitiesVariantWorkabstractingbasebiobankbioinformatics resourcebioinformatics toolbiomedical informaticsclinical investigationdata resourcedesignexperiencehigh standardimaging approachimprovedinnovationinterestmicroscopic imagingonline tutorialpopulation stratificationsexsingle cell sequencingskin disordersuccesstranslational clinical trial
项目摘要
PROJECT SUMMARY
The major focus of Core C, the Data Science and Informatics (DSI) core, is to facilitate human discovery
through basic and translational research in cutaneous biology and disease by providing assistance to
investigators on the planning, design, and analysis (both statistical and informatics) of studies of the skin. The
DSI interacts directly with the other Resource Cores and the overall theme of the SBDRC in that bench and
human translational research needs to be well designed, properly conducted, and correctly analyzed in order
to maintain high standards of rigor and reproducibility. DSI achieves these goals by a combination of
epidemiologic, statistical and informatics approaches. By its very nature, DSI will continue to be highly
collaborative and will add value to the other cores. DSI Core directors will encourage investigators interested in
cutaneous research to work with Core faculty and staff at every stage of design and analysis, thus promoting a
team science approach from hypothesis inception to study execution, analysis, and interpretation. DSI’s
functions are represented by two Aims that leverage expertise of Core faculty and staff in the following areas:
Aim 1: To provide study design and biostatistical services to SBDRC Core users, including: 1) Study design
methodologies necessary to design and implement rigorous experimental and clinical investigations; 2)
Statistical methodologies critical for the evaluation of each project’s research hypotheses including
consideration of sex as a biologic variable; 3) Interpretation of research data to make scientifically and
statistically appropriate statements; 4) Translation of bench findings to human research using translational and
clinical trial designs. Aim 2: To provide biomedical informatics & computational dermatology services to
SBDRC Core users, including: 1) Bioinformatics approaches to allow for the analysis and conceptualization of
large genomic and metagenomic datasets; 2) Artificial intelligence-guided approaches to quantify patterns and
textures in microscopy images; 3) Medical informatics approaches to query medical records databases from
UPHS and extramural sources. A critical barrier to progress in cutaneous biology and skin disease research is
the lack of integration of biostatistical, epidemiological (both quantitative and qualitative), and informatics
approaches to basic and clinical investigation. DSI will significantly add to the overall success of the SBDRC by
addressing this barrier and the specific need for these approaches in human translational research.
Implementing such approaches from inception through project completion will improve the reproducibility, rigor,
and validity of research findings. The other SBDRC Resource Cores and the Administrative Core will be able to
leverage the expertise of DSI faculty and staff to enhance the efficiency, reproducibility, and validity of research
promoted by the SBDRC.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Margolis其他文献
David Margolis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Margolis', 18)}}的其他基金
A randomized, double-blind, multi-center comparative effectiveness study of spironolactone versus doxycycline hyclate for the treatment of acne in women
螺内酯与盐酸强力霉素治疗女性痤疮的随机、双盲、多中心比较疗效研究
- 批准号:
10296086 - 财政年份:2021
- 资助金额:
$ 23.37万 - 项目类别:
A randomized, double-blind, multi-center comparative effectiveness study of spironolactone versus doxycycline hyclate for the treatment of acne in women
螺内酯与盐酸强力霉素治疗女性痤疮的随机、双盲、多中心比较疗效研究
- 批准号:
10470869 - 财政年份:2021
- 资助金额:
$ 23.37万 - 项目类别:
Comparative effectiveness of spironolactone versus oral tetracycline-class antibiotics for the treatment of moderate to severe acne in women
螺内酯与口服四环素类抗生素治疗女性中度至重度痤疮的疗效比较
- 批准号:
9815052 - 财政年份:2019
- 资助金额:
$ 23.37万 - 项目类别:
NOS1AP and Capon Associated Impaired Healing in Those with Diabetic Foot Ulcers
NOS1AP 和 Capon 与糖尿病足溃疡患者的愈合受损相关
- 批准号:
9925084 - 财政年份:2018
- 资助金额:
$ 23.37万 - 项目类别:
African-Americans with Atopic Dermatitis: Skin Barrier and Immune
患有特应性皮炎的非裔美国人:皮肤屏障和免疫
- 批准号:
9228322 - 财政年份:2016
- 资助金额:
$ 23.37万 - 项目类别:
African-Americans with Atopic Dermatitis: Skin Barrier and Immune
患有特应性皮炎的非裔美国人:皮肤屏障和免疫
- 批准号:
9868281 - 财政年份:2016
- 资助金额:
$ 23.37万 - 项目类别:
Stem cell mobilization and diabetic skin ulcers
干细胞动员和糖尿病皮肤溃疡
- 批准号:
8538377 - 财政年份:2012
- 资助金额:
$ 23.37万 - 项目类别:
Stem cell mobilization and diabetic skin ulcers
干细胞动员和糖尿病皮肤溃疡
- 批准号:
8370929 - 财政年份:2012
- 资助金额:
$ 23.37万 - 项目类别:
Stem cell mobilization and diabetic skin ulcers
干细胞动员和糖尿病皮肤溃疡
- 批准号:
8731122 - 财政年份:2012
- 资助金额:
$ 23.37万 - 项目类别:














{{item.name}}会员




